20 May 05
In addition to the traditional clinical needs, such as efficacy and resistance profile, product characteristics such as dosing and side effects can be fundamental in maintaining market share in the maturing antiretroviral market. In response to the launch of two once-daily protease inhibitors (PI), Abbott has reformulated its leading PI drug, Kaletra (lopinavir/ritonavir) in a once-daily dose.
18 May 05
With UK MP’s, Committees, Regulatory bodies, Health Services and Companies looking for someone to blame for the dangers of patient non-compliance and drug safety issues it’s time to learn how the simplest technology can deliver the biggest rewards and bring you closer to your patients.
13 May 05
For decades, AstraZeneca's tamoxifen has been the standard therapy for hormone-receptor positive breast cancer patients post-surgery. Nearly two-thirds of early-stage breast cancer patients receive the drug post surgery. Now however newer antihormonal agents called aromatase inhibitors, which lower the estrogen level in the body are increasingly being used in place of tamoxifen.
12 May 05
The idea of developing cancer vaccines is far from a novel concept. In fact initial attempts using tumor immunotherapy to combat cancer were made in the late 19th century by the American Dr William Coley. Unfortunately, despite Dr Coley's early efforts and those of numerous others since, there is still no effective therapeutic cancer vaccine on the market.
29 Apr 05
The Healthcare Industry is currently experiencing the effects of a global shortage of qualified and experienced clinical research professionals – and this situation has evolved into the industry’s very own version of ‘Catch 22’. While employers are looking to hire candidates who are already experienced in the practice of clinical research, new Life Science graduates and others wishing to start on a career in the Healthcare Industry are unable to gain such experience without first being hired.
European Director CRAcademy
15 Apr 05
The government's Health Select Committee has published a stinging attack on the UK pharmaceutical industry. In a report spanning 126 pages and consisting of 48 conclusions and recommendations, the committee has lambasted the way in which the UK pharmaceutical industry conducts its business and the motives by which it is driven. Datamonitor's Duncan Emerton looks at the details...
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.